Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Top 10 Neuroscience Projects To Watch 2013 14"

10:40 EDT 24th July 2014 | BioPortfolio

Matching Channels

Mesenchymal Epithelial Transition factor c MET

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

AstraZeneca

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and em...

Staphylococcal aureus infections

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the...

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in...

Matching News

Neuroscience companies sprout up in Boston

TweetIn our December 10, 2013 blog article that focused on Novartis’ new neuroscience division, we briefly mentioned two young Cambridge MA neuroscience specialty companies–Rodin Therapeut...

The Most Promising Drugs to Watch Changing Phase and Receiving Approval Q4 2013

The latest The Ones to Watch report is an expert review of the most promising drugs to watch launched from October to December 2013. These pharmaceuticals are changing clinical phase and receiving app...

Companies To Watch: A Roundup Of Life Science Developments And Technologies

Each month, Companies to Watch spotlights one company that has received scant press coverage but, nonetheless, contains an especially interesting story. At the end of this past year, we thought it wou...

AT&T Among First To Offer LG G Watch

DALLAS, June 25, 2014 /PRNewswire/ --AT&T today announced it will be among the first U.S. carriers to bring the LG G Watch to its portfolio of accessories. "The LG G Watch is a great addition to A...

There’s no longer anything novel about fitness watches — but at least Withings’ looks good

Withings describes its new Activité watch like this: “The first Swiss made watch that happens to be an activity tracker.” And that’s the coolest thing about this watch. There’s no...

Singapore's largest neuroscience research institute launched

(SingHealth) The National Neuroscience Research Institute Singapore -- a joint venture by the National Neuroscience Institute and Duke-NUS Graduate Medical School -- has been launched to improve treat...

20 Promising Drugs to Watch in 2014

Peter Robins writes for Outsourced Pharma on promising drugs changing clinical phase or receiving approval. Numerous drug therapies changed clinical phase, received approval, and launched in the final...

Neurobiologist Thomas Jessell to be honored with 2014 Gruber Neuroscience Prize

Thomas Jessell, PhD, the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is the recipient of the...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement